Balyasny Asset Management
TDOC icon

Balyasny Asset Management’s Teladoc Health TDOC Stock Holding History

Balyasny Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Sell
42,284
-44,354
-51% -$295K ﹤0.01% 2656
2026
Q1 		$472K Buy
86,638
+28,268
+48% +$159K ﹤0.01% 2393
2025
Q4 		$409K Buy
58,370
+8,023
+16% +$62.8K ﹤0.01% 2608
2025
Q3 		$389K Buy
50,347
+8,671
+21% +$67.7K ﹤0.01% 2490
2025
Q2 		$363K Buy
+41,676
New +$302K ﹤0.01% 2415
2024
Q3 		– Sell
-10,311
Closed -$101K – 3155
2024
Q2 		$101K Sell
10,311
-831,619
-99% -$10.1M ﹤0.01% 2403
2024
Q1 		$12.7M Buy
841,930
+574,862
+215% +$10.4M 0.02% 822
2023
Q4 		$5.76M Sell
267,068
-1,199,418
-82% -$22.1M 0.01% 1071
2023
Q3 		$27.3M Sell
1,466,486
-239,358
-14% -$5.59M 0.06% 461
2023
Q2 		$43.2M Buy
1,705,844
+1,295,092
+315% +$32.6M 0.1% 293
2023
Q1 		$10.6M Sell
410,752
-234,297
-36% -$6.27M 0.03% 751
2022
Q4 		$15.3M Buy
645,049
+226,159
+54% +$6.1M 0.04% 582
2022
Q3 		$10.6M Sell
418,890
-379,166
-48% -$13.3M 0.03% 662
2022
Q2 		$26.5M Buy
+798,056
New +$33.9M 0.09% 331
2021
Q4 		– Sell
-19,945
Closed -$2.53M – 2584
2021
Q3 		$2.53M Buy
19,945
+10,363
+108% +$1.51M 0.01% 1051
2021
Q2 		$1.59M Sell
9,582
-70,365
-88% -$11.4M 0.01% 1091
2021
Q1 		$14.5M Buy
79,947
+66,188
+481% +$15.4M 0.07% 373
2020
Q4 		$2.75M Sell
13,759
-41,976
-75% -$8.54M 0.02% 802
2020
Q3 		$12.2M Buy
+55,735
New +$11.8M 0.09% 330
2020
Q2 		– Sell
-13,795
Closed -$2.14M – 1474
2020
Q1 		$2.14M Buy
+13,795
New +$1.6M 0.03% 607
2019
Q3 		– Sell
-21,567
Closed -$1.43M – 1576
2019
Q2 		$1.43M Buy
+21,567
New +$1.26M 0.01% 979
2018
Q4 		– Sell
-21,651
Closed -$1.87M – 1751
2018
Q3 		$1.87M Sell
21,651
-59,263
-73% -$4.22M 0.01% 1002
2018
Q2 		$4.7M Buy
+80,914
New +$3.95M 0.02% 681

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Balyasny Asset Management's TDOC Position: Q2 2026 in Review

Balyasny Asset Management reduced its Teladoc Health (TDOC) stake by 51% in Q2 2026, selling an estimated $295K and leaving 42,284 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #2656.

Balyasny Asset Management first reported a position in TDOC in Q2 2018 and has held it in 23 quarters since. The position peaked at $43.2M in Q2 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Balyasny Asset Management held 42,284 shares of Teladoc Health worth $359K as of Q2 2026.
  • Balyasny Asset Management sold 44,354 Teladoc Health shares in Q2 2026, an estimated $295K.
  • Teladoc Health made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2656 holding.
  • Balyasny Asset Management first reported a position in Teladoc Health in Q2 2018 and has held it in 23 quarters since.
  • Balyasny Asset Management's Teladoc Health position peaked at $43.2M in Q2 2023.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.